Trial Profile
Double Blinded Study of the Effects of Pioglitazone in Combination With Atorvastatin in Comparison to Atorvastatin Treatment Alone on Intima-Media Thickness in Patients at Risk for Vascular Complications.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Atorvastatin
- Indications Atherosclerosis
- Focus Pharmacodynamics
- Sponsors Takeda Pharma
- 23 Oct 2008 New trial record.